SERPINB2 and cancer: Belfiore et al. utilized single-molecule fluorescence imaging to quantitatively assess the content of targeting molecules on functionalized liposomes, notably plasminogen activator inhibitor-2 (PAI-2) and trastuzumab (TZ, Herceptin®), targeting cancer cell surface biomarkers, benefiting the development of targeted liposomal drug delivery systems [104].